Back
Day Range
$207.92
$212.22
52-Week Range
$120.72
$233.60
Volume
1,831,772
50D / 200D Avg
$217.05
/
$182.52
Prev Close
$207.23
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 31.9 | 0.3 |
| P/B | — | 3.0 |
| ROE % | — | 3.7 |
| Net Margin % | 0.7 | 3.8 |
| Rev Growth 5Y % | 8.2 | 10.0 |
| D/E | — | 0.2 |
Analyst Price Target
Hold
$252.33
+19.4%
Low: $220.00
High: $275.00
Forward P/E
20.49
Forward EPS
$10.31
EPS Growth (est.)
+0.0%
Est. Revenue
258.62B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$17.35
$16.88 – $17.96
|
374.32B | 1 |
| FY2029 |
$14.88
$14.48 – $15.40
|
334.38B | 1 |
| FY2028 |
$13.03
$11.84 – $14.17
|
303.92B | 5 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-05 | $2.34 | $2.63 | +12.4% |
| 2025-10-30 | $2.18 | $2.55 | +17.0% |
| 2025-08-12 | $2.04 | $2.08 | +2.0% |
| 2025-05-01 | $2.17 | $2.35 | +8.3% |
| 2025-01-30 | $1.74 | $1.93 | +10.9% |
| 2024-11-01 | $1.62 | $1.88 | +16.0% |
| 2024-08-14 | $1.73 | $1.84 | +6.4% |
| 2024-05-02 | $1.95 | $2.08 | +6.7% |
Dividend History
7 yr streakYield
0.01%
Payout Ratio
0.32%
Growth (3Y)
0.90%
Growth (5Y)
0.95%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Apr 01, 2026 | Apr 15, 2026 | $0.51 | 0.97% |
| Jan 02, 2026 | Jan 15, 2026 | $0.51 | 0.99% |
| Oct 01, 2025 | Oct 15, 2025 | $0.51 | 1.29% |
| Jul 01, 2025 | Jul 15, 2025 | $0.51 | 1.23% |
| Apr 01, 2025 | Apr 15, 2025 | $0.51 | 1.47% |
| Jan 02, 2025 | Jan 15, 2025 | $0.51 | 1.71% |
| Oct 01, 2024 | Oct 15, 2024 | $0.51 | 1.82% |
| Jul 01, 2024 | Jul 15, 2024 | $0.51 | 2.05% |
| Mar 28, 2024 | Apr 15, 2024 | $0.50 | 1.79% |
| Dec 29, 2023 | Jan 15, 2024 | $0.50 | 1.98% |
| Oct 02, 2023 | Oct 15, 2023 | $0.50 | 2.31% |
| Jun 30, 2023 | Jul 15, 2023 | $0.50 | 2.10% |
| Mar 31, 2023 | Apr 15, 2023 | $0.50 | 2.63% |
| Dec 30, 2022 | Jan 15, 2023 | $0.50 | 2.57% |
| Sep 30, 2022 | Oct 15, 2022 | $0.50 | 2.96% |
| Jun 30, 2022 | Jul 15, 2022 | $0.50 | 3.77% |
| Mar 31, 2022 | Apr 15, 2022 | $0.49 | 3.46% |
| Dec 31, 2021 | Jan 15, 2022 | $0.49 | 3.80% |
| Sep 30, 2021 | Oct 15, 2021 | $0.49 | 3.95% |
| Jun 30, 2021 | Jul 15, 2021 | $0.49 | 3.41% |
Key Takeaways
Revenue grew 8.19% annually over 5 years — modest growth
Earnings grew 83.22% over the past year
Generating 1.85B in free cash flow
P/E of 31.85 — premium valuation
PEG of 0.30 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 10.06%
Growth
Revenue Growth (5Y)
8.19%
Revenue (1Y)-1.87%
Earnings (1Y)83.22%
FCF Growth (3Y)-11.52%
Quality
Return on Equity
N/A
ROIC25.99%
Net Margin0.70%
Op. Margin1.02%
Safety
Debt / Equity
N/A
Current Ratio0.94
Interest Coverage10.58
Valuation
P/E Ratio
31.85
Forward P/E20.01
P/B RatioN/A
EV/EBITDA24.26
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1.87% | Revenue Growth (3Y) | 4.20% |
| Earnings Growth (1Y) | 83.22% | Earnings Growth (3Y) | 117.49% |
| Revenue Growth (5Y) | 8.19% | Earnings Growth (5Y) | 26.43% |
| Profitability | |||
| Revenue (TTM) | 222.58B | Net Income (TTM) | 1.56B |
| ROE | N/A | ROA | 2.94% |
| Gross Margin | 3.67% | Operating Margin | 1.02% |
| Net Margin | 0.70% | Free Cash Flow (TTM) | 1.85B |
| ROIC | 25.99% | FCF Growth (3Y) | -11.52% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.94 |
| Interest Coverage | 10.58 | ||
| Dividends | |||
| Dividend Yield | 0.01% | Payout Ratio | 0.32% |
| Dividend Growth (3Y) | 0.90% | Dividend Growth (5Y) | 0.95% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 31.85 | Forward P/E | 20.01 |
| P/B Ratio | N/A | P/S Ratio | 0.22 |
| PEG Ratio | 0.30 | Forward PEG | N/A |
| EV/EBITDA | 24.26 | Fwd EV/EBITDA | 8.87 |
| Forward P/S | 0.19 | Fwd Earnings Yield | 5.00% |
| FCF Yield | 3.72% | ||
| Market Cap | 49.72B | Enterprise Value | 55.20B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 222.58B | 226.83B | 204.98B | 181.33B | 162.47B |
| Net Income | 1.56B | 852.00M | 330.00M | -938.00M | 611.00M |
| EPS (Diluted) | 6.45 | 3.45 | 1.26 | -3.34 | 2.08 |
| Gross Profit | 8.17B | 7.41B | 6.89B | 6.48B | 6.78B |
| Operating Income | 2.28B | 1.24B | 752.00M | -607.00M | 472.00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 53.12B | 45.12B | 43.35B | 43.88B | 44.45B |
| Total Liabilities | 55.76B | 48.33B | 46.31B | 44.58B | 42.66B |
| Shareholders' Equity | -2.78B | -3.21B | -2.96B | -709.00M | 1.79B |
| Total Debt | 9.35B | 5.61B | 5.18B | 5.81B | 6.72B |
| Cash & Equivalents | 3.87B | 5.13B | 4.08B | 4.72B | 3.41B |
| Current Assets | 36.37B | 34.88B | 33.74B | 32.94B | 31.05B |
| Current Liabilities | 38.90B | 35.64B | 33.74B | 30.55B | 27.62B |